Esperanza Papadopoulos

10PUBLICATIONS
45CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
Regional practice differences significantly impact benefit from post-HCT gilteritinib for FLT3-ITD AML.

|Jul 01, 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia.

Mark J Levis, Mehdi Hamadani, Brent R Logan

|Jun 12, 2025
Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse posttransplant.

Susan DeWolf, Jason Kuttiyara, Paola Vinci

|May 27, 2025
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation.

Ioannis Politikos, Samantha Brown, Joshua A Fein

|Jan 08, 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.

Mark J Levis, Mehdi Hamadani, Brent R Logan

|Aug 19, 2024
Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity.

Brian C Shaffer, Samantha Brown, Stephanie Chinapen

Pageof 2

Frequent Collaborators

6 joint publications

Sergio Giralt

6 joint publications

Miguel-Angel Perales

5 joint publications

Andromachi Scaradavou

5 joint publications

Stephanie Chinapen